| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233992 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
Urinary symptom flare is a common, transient phenomenon after prostate brachytherapy. A greater baseline IPSS and maximal postimplant IPSS were the strongest predictive factors. Flare was associated with a greater incidence of late RTOG Grade 3 urinary toxicity and greater rate of late RTOG Grade 2 or greater rectal toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mira M.D., Stacy M.D., Veronika M.Sc., Tom M.D., Mitchell M.D.C.M., Ingrid Ph.D., Vincent M.Sc., W. James M.D.,